Dr. Steven Joseph Gregoritch, MD

Dr. Gregoritch practices at SSM Health Monroe Hospital in Monroe, Wisconsin, part of SSM Health Care.

Dr. Gregoritch's NPI, 1841290772, was assigned on July 21, 2005. Dr. Gregoritch graduated from Indiana University School Of Medicine in 1986. Dr. Gregoritch holds New York license 171770.

Dr. Gregoritch's primary practice is SSM Health Monroe Hospital, at 515 22nd Ave, Monroe, WI 53566 in Green County. The practice phone is (608) 324-2000.

Dr. Gregoritch's primary practice is SSM Health Monroe Hospital in Monroe, Wisconsin, part of SSM Health Care. The medical group on file is SSM Health Monroe Clinic Medical Group. Dmand AI also links Dr. Gregoritch to 1 more home health agency, 1 hospice and 1 medical group, each named with a free account. Dr. Gregoritch's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gregoritch practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Gregoritch's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gregoritch is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gregoritch's licenses on file in 8 states: New York, Iowa, Ohio, Pennsylvania, Indiana, Wisconsin, Louisiana and Arkansas.

Dmand AI lists bladder cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Gregoritch treats.

CMS data shows 356 Medicare services from Dr. Gregoritch across 5 procedure codes in 2024, for 22 Medicare patients. Medicare paid $17,268 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 22 Medicare patients who saw Dr. Gregoritch in 2024. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gregoritch's median patient age at 74, with 47% women.

In 2024, Dr. Gregoritch wrote 79 Medicare Part D claims for 30 patients. 89% of them were for generic drugs. CMS names the drug for 46 of them, across 2 drugs with 11 or more claims each, at $664 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

Dr. Gregoritch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Gregoritch. Dr. Gregoritch's most frequent co-author is Robert M. Lifeso, MD.

Dmand AI links Dr. Gregoritch to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 8 general payments to Dr. Gregoritch from 5 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $163.

Dr. Gregoritch graduated from Indiana University School Of Medicine in 1986. Dr. Gregoritch is a member of ACP, ACRO and ASTRO.

Dr. Gregoritch is in network with 6 carriers, including Aetna, Highmark and Elevance. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.